| # | Title | Journal | Year | Citations |
|---|
|
| 1 | European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection | Clinical Microbiology and Infection | 2014 | 945 |
| 2 | The global threat of antimicrobial resistance: science for intervention | New Microbes and New Infections | 2015 | 841 |
| 3 | Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance | Lancet Infectious Diseases, The | 2021 | 638 |
| 4 | Protection against a Malaria Challenge by Sporozoite Inoculation | New England Journal of Medicine | 2009 | 545 |
| 5 | A New Aspergillus fumigatus Resistance Mechanism Conferring In Vitro Cross-Resistance to Azole Antifungals Involves a Combination of cyp51A Alterations | Antimicrobial Agents and Chemotherapy | 2007 | 452 |
| 6 | Managing COVID-19 in Low- and Middle-Income Countries | JAMA - Journal of the American Medical Association | 2020 | 437 |
| 7 | Genus- and species-specific identification of mycoplasmas by 16S rRNA amplification | Applied and Environmental Microbiology | 1992 | 435 |
| 8 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline | Clinical Infectious Diseases | 2020 | 423 |
| 9 | Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline | European Respiratory Journal | 2020 | 419 |
| 10 | Possible Environmental Origin of Resistance of Aspergillus fumigatus to Medical Triazoles | Applied and Environmental Microbiology | 2009 | 404 |
| 11 | Targeting Plasmodium PI(4)K to eliminate malaria | Nature | 2013 | 384 |
| 12 | Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline | Clinical Infectious Diseases | 2020 | 383 |
| 13 | US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis | Thorax | 2016 | 366 |
| 14 | General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections | Journal of Clinical Microbiology | 1992 | 348 |
| 15 | Triazole Fungicides Can Induce Cross-Resistance to Medical Triazoles in Aspergillus fumigatus | PLoS ONE | 2012 | 331 |
| 16 | Trained immunity, tolerance, priming and differentiation: distinct immunological processes | Nature Immunology | 2021 | 331 |
| 17 | Fusarium: Molecular Diversity and Intrinsic Drug Resistance | PLoS Pathogens | 2016 | 326 |
| 18 | ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures | Clinical Microbiology and Infection | 2012 | 319 |
| 19 | The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries | Lancet Microbe, The | 2022 | 303 |
| 20 | BCG Vaccination in Humans Elicits Trained Immunity via the Hematopoietic Progenitor Compartment | Cell Host and Microbe | 2020 | 301 |
| 21 | Detection of High-grade Prostate Cancer Using a Urinary Molecular Biomarker–Based Risk Score | European Urology | 2016 | 300 |
| 22 | Review of influenza-associated pulmonary aspergillosis in ICU patients and proposal for a case definition: an expert opinion | Intensive Care Medicine | 2020 | 299 |
| 23 | Quality of powdered substitutes for breast milk with regard to members of the family Enterobacteriaceae | Journal of Clinical Microbiology | 1988 | 292 |
| 24 | US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary | Thorax | 2016 | 284 |
| 25 | Society's failure to protect a precious resource: antibiotics | Lancet, The | 2011 | 265 |
| 26 | Clinical implications of globally emerging azole resistance in Aspergillus fumigatus | Philosophical Transactions of the Royal Society B: Biological Sciences | 2016 | 252 |
| 27 | Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species | Antimicrobial Agents and Chemotherapy | 2012 | 247 |
| 28 | Coxsackievirus protein 2B modifies endoplasmic reticulum membrane and plasma membrane permeability and facilitates virus release | EMBO Journal | 1997 | 243 |
| 29 | ECIL guidelines for the diagnosis of Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients | Journal of Antimicrobial Chemotherapy | 2016 | 241 |
| 30 | ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients | Journal of Antimicrobial Chemotherapy | 2016 | 227 |
| 31 | Azole-resistance in Aspergillus: Proposed nomenclature and breakpoints | Drug Resistance Updates | 2009 | 225 |
| 32 | Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT). A Prospective, Open-Label, Randomized Study | American Journal of Respiratory and Critical Care Medicine | 2018 | 223 |
| 33 | Healthcare-associated prosthetic heart valve, aortic vascular graft, and disseminatedMycobacterium chimaerainfections subsequent to open heart surgery | European Heart Journal | 2015 | 219 |
| 34 | Protein Binding: Do We Ever Learn? | Antimicrobial Agents and Chemotherapy | 2011 | 217 |
| 35 | Antimalarial efficacy of MMV390048, an inhibitor of Plasmodium phosphatidylinositol 4-kinase | Science Translational Medicine | 2017 | 211 |
| 36 | Global outbreak of severe Mycobacterium chimaera disease after cardiac surgery: a molecular epidemiological study | Lancet Infectious Diseases, The | 2017 | 211 |
| 37 | Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study | Clinical Infectious Diseases | 2019 | 210 |
| 38 | Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology | Lancet Infectious Diseases, The | 2021 | 205 |
| 39 | Three Members of the 6-cys Protein Family of Plasmodium Play a Role in Gamete Fertility | PLoS Pathogens | 2010 | 202 |
| 40 | Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent? | Antimicrobial Agents and Chemotherapy | 2013 | 196 |
| 41 | Phase 1/2a Study of the Malaria Vaccine Candidate Apical Membrane Antigen-1 (AMA-1) Administered in Adjuvant System AS01B or AS02A | PLoS ONE | 2009 | 186 |
| 42 | Influenza-associated Aspergillosis in Critically Ill Patients | American Journal of Respiratory and Critical Care Medicine | 2017 | 184 |
| 43 | Non-tuberculous mycobacterial pulmonary disease | European Respiratory Journal | 2019 | 183 |
| 44 | Phylogeography and evolutionary patterns in <I>Sporothrix</I> spanning more than 14 000 human and animal case reports | Persoonia: Molecular Phylogeny and Evolution of Fungi | 2015 | 182 |
| 45 | Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease: an NTM-NET consensus statement | European Respiratory Journal | 2018 | 180 |
| 46 | Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective | Drug Resistance Updates | 2011 | 179 |
| 47 | Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing | MBio | 2015 | 177 |
| 48 | Selective digestive tract decontamination and selective oropharyngeal decontamination and antibiotic resistance in patients in intensive-care units: an open-label, clustered group-randomised, crossover study | Lancet Infectious Diseases, The | 2011 | 175 |
| 49 | Outcomes of controlled human malaria infection after BCG vaccination | Nature Communications | 2019 | 175 |
| 50 | Protection against malaria after immunization by chloroquine prophylaxis and sporozoites is mediated by preerythrocytic immunity | Proceedings of the National Academy of Sciences of the United States of America | 2013 | 174 |
